Of note, we observed stronger reduction of the activation of ERK1/2 in vivo compared to in cell lines, which probably reflects the additional effect of G31P on tumor microenvironment that offers input to the Ras-MAPK cascade. The gene discussed is MAPK3; the disease is neoplasm.